Ovid Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 23, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	162	64	206	123	192	120
Market Cap Growth	242.20%	-68.90%	67.89%	-36.19%	60.44%	-32.26%
Enterprise Value	152	18	142	9	15	49
Last Close Price	1.25	0.89	3.00	1.68	2.74	1.83
PE Ratio	-	-	-	-	1.82	-
PS Ratio	28.83	117.14	580.59	87.22	1.05	11.61
PB Ratio	4.26	0.97	2.59	0.99	1.22	3.36
P/TBV Ratio	4.26	0.97	2.60	0.99	1.22	3.38
P/FCF Ratio	-	-	-	-	1.85	-
P/OCF Ratio	-	-	-	-	1.84	-
EV/Sales Ratio	27.16	32.98	400.05	6.30	0.08	4.73
EV/EBITDA Ratio	-	-	-	-	0.14	-
EV/EBIT Ratio	-	-	-	-	0.14	-
EV/FCF Ratio	-4.71	-	-	-	0.14	-
Debt / Equity Ratio	0.31	0.22	0.18	0.13	-	-
Net Debt / Equity Ratio	-0.26	-0.56	-1.02	-0.85	-1.04	-1.65
Net Debt / EBITDA Ratio	0.31	0.66	1.58	2.04	-1.51	0.89
Net Debt / FCF Ratio	0.31	0.68	1.96	1.99	-1.59	1.39
Asset Turnover	0.08	0.01	0.00	0.01	1.54	0.16
Quick Ratio	3.77	5.04	9.23	18.45	12.69	3.27
Current Ratio	4.24	5.32	9.55	18.79	12.87	3.39
Return on Equity (ROE)	-60.06%	-33.88%	-47.57%	-34.72%	109.98%	-142.60%
Return on Assets (ROA)	-29.33%	-30.90%	-24.05%	-19.85%	57.40%	-64.93%
Return on Invested Capital (ROIC)	-121.33%	-418.97%	-648.00%	-392.69%	-	-
Return on Capital Employed (ROCE)	-68.50%	-71.50%	-43.40%	-37.50%	69.10%	-151.20%
Earnings Yield	-18.82%	-39.87%	-23.00%	-41.33%	56.20%	-55.30%
FCF Yield	-19.92%	-84.50%	-20.13%	-43.07%	54.18%	-35.29%
Buyback Yield / Dilution	-0.35%	-0.46%	-0.22%	-3.46%	-16.45%	-49.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.